Mason Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Mason Capital Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,381,898	Closed	-$239M	–	34
2015 Q1	$239M	Buy	+1,381,898	New	+$203M	4.01%	12
2014 Q4	–	Sell	-531,045	Closed	-$83M	–	44
2014 Q3	$83M	Buy	+531,045	New	+$77M	0.87%	31

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Mason Capital Management's SLXP Position: Q2 2015 in Review

Mason Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 1,381,898 shares — an estimated $239M sold.

Mason Capital Management first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $239M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Mason Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Mason Capital Management sold 1,381,898 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $239M.
Mason Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
Mason Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $239M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Mason Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.